Progesterone rise on the day of human chorionic gonadotropin administration impairs pregnancy outcome in day 3 single-embryo transfer, while has no effect on day 5 single blastocyst transfer

Fertil Steril. 2009 Mar;91(3):949-52. doi: 10.1016/j.fertnstert.2006.12.064. Epub 2007 Jun 6.

Abstract

Four hundred eighty-two patients undergoing single ET with GnRH-antagonist/recFSH protocol were analyzed. The incidence of premature luteinization (P above 1.5 ng/mL on the day of hCG administration) was 18.2%. Even modest rises of P in the follicular phase have detrimental effect on the implantation potential of a good-quality cleavage stage embryo. On the contrary, premature luteinization in the blastocyst subgroup had no effect on the pregnancy outcome.

Publication types

  • Comparative Study

MeSH terms

  • Adult
  • Chorionic Gonadotropin / administration & dosage*
  • Drug Therapy, Combination
  • Embryo Implantation
  • Embryo Transfer*
  • Female
  • Fertility Agents, Female / administration & dosage*
  • Follicle Stimulating Hormone / administration & dosage
  • Gonadotropin-Releasing Hormone / antagonists & inhibitors
  • Hormone Antagonists / administration & dosage
  • Humans
  • Luteal Phase / blood
  • Luteal Phase / drug effects*
  • Ovulation Induction / adverse effects*
  • Pregnancy
  • Pregnancy Outcome*
  • Progesterone / blood*
  • Prospective Studies
  • Recombinant Proteins / administration & dosage
  • Time Factors
  • Up-Regulation

Substances

  • Chorionic Gonadotropin
  • Fertility Agents, Female
  • Hormone Antagonists
  • Recombinant Proteins
  • Gonadotropin-Releasing Hormone
  • Progesterone
  • Follicle Stimulating Hormone